| Predicate |
Object |
| contentType |
Clinical Trial|Journal Article |
| endingPage |
1200 |
| issn |
0277-5379 |
| issueIdentifier |
10 |
| pageRange |
1198-1200 |
| publicationName |
European journal of cancer (Oxford, England : 1990) |
| startingPage |
1198 |
| bibliographicCitation |
Judson IR. Phase II studies: Wrong doses, wrong patients? European Journal of Cancer and Clinical Oncology. 1991 Oct;27(10):1198–200. doi: 10.1016/0277-5379(91)90080-w. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_addc58b46c1d862db65fa77b459d0cbb |
| date |
199110 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/1835585
https://doi.org/10.1016/0277-5379%2891%2990080-w |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3632
https://portal.issn.org/resource/ISSN/0277-5379 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/ |
| title |
Phase II studies: Wrong doses, wrong patients? |
| discusses |
http://id.nlm.nih.gov/mesh/M0001483
http://id.nlm.nih.gov/mesh/M0022149 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D009369Q000188
http://id.nlm.nih.gov/mesh/D000970Q000008 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D011379
http://id.nlm.nih.gov/mesh/D004334
http://id.nlm.nih.gov/mesh/D014408Q000097
http://id.nlm.nih.gov/mesh/D000970Q000493
http://id.nlm.nih.gov/mesh/D004351
http://id.nlm.nih.gov/mesh/D000970Q000627
http://id.nlm.nih.gov/mesh/D004341Q000379 |